Please use this identifier to cite or link to this item: https://doi.org/10.1007/s12185-009-0432-0
Title: Iron chelation therapy in the management of thalassemia: The Asian perspectives
Authors: Viprakasit, V.
Lee-Lee, C.
Chong, Q.T. 
Lin, K.-H.
Khuhapinant, A.
Keywords: Deferasirox
Deferiprone
Deferoxamine
Iron chelation therapy
Thalassemia
Issue Date: 2009
Source: Viprakasit, V., Lee-Lee, C., Chong, Q.T., Lin, K.-H., Khuhapinant, A. (2009). Iron chelation therapy in the management of thalassemia: The Asian perspectives. International Journal of Hematology 90 (4) : 435-445. ScholarBank@NUS Repository. https://doi.org/10.1007/s12185-009-0432-0
Abstract: Worldwide, thalassemia is the most commonly inherited hemolytic anemia, and it is most prevalent in Asia and the Middle East. Iron overload represents a significant problem in patients with transfusion-dependent β-thalassemia. Chelation therapy with deferoxamine has traditionally been the standard therapeutic option but its usage is tempered by suboptimal patient compliance due to the discomfort and demands associated with the administration regimen. Therefore, a great deal of attention has been focused on the development of oral chelating agents. Deferiprone, even though available for nearly two decades in Asia with recent encouraging data on cardiac iron removal and long-term efficacy, has serious adverse effects including agranulocytosis and neutropenia which has impeded it from routine clinical practice. A novel oral chelator; deferasirox is effective throughout a 24 h dosing period and both preclinical and clinical data indicate that it successfully removes both hepatic and cardiac iron. In Asia, optimal management of severe thalassemia patients and the availability and access to oral iron chelators still presents a major challenge in many countries. In this regard, the development and implementation of consensus guidelines for management of Asian patients with transfusion-dependent thalassemia will be a major step towards improving and maintaining the continuity of patient care. © 2009 The Japanese Society of Hematology.
Source Title: International Journal of Hematology
URI: http://scholarbank.nus.edu.sg/handle/10635/129976
ISSN: 09255710
DOI: 10.1007/s12185-009-0432-0
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

37
checked on Feb 27, 2018

WEB OF SCIENCETM
Citations

33
checked on Feb 27, 2018

Page view(s)

8
checked on Feb 25, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.